Literature DB >> 22873767

Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.

Mathieu Hatt1, Ruud van Stiphout, Adrien le Pogam, Guido Lammering, Dimitris Visvikis, Philippe Lambin.   

Abstract

BACKGROUND: The objectives of this study were to investigate the predictive value of sequential (18)F-FDG PET scans for pathological tumor response grade (TRG) after preoperative chemoradiotherapy (PCRT) in locally advanced rectal cancer (LARC) and the impact of partial volume effects correction (PVC).
METHODS: Twenty-eight LARC patients were included. Responders and non-responders status were determined in histopathology. PET indices [SUV max and mean, volume and total lesion glycolysis (TLG)] at baseline and their evolution after one and two weeks of PCRT were extracted by delineation of the PET images, with or without PVC. Their predictive value was investigated using Mann-Whitney-U tests and ROC analysis.
RESULTS: Within baseline parameters, only SUVmean was correlated with response. No evolution after one week was predictive of the response, whereas after two weeks all the parameters except volume were, the best prediction being obtained with TLG (AUC 0.79, sensitivity 63%, specificity 92%). PVC had no significant impact on these results.
CONCLUSION: Several PET indices at baseline and their evolution after two weeks of PCRT are good predictors of response in LARC, with or without PVC, whereas results after one week are suboptimal. Best predictor was TLG reduction after two weeks, although baseline SUVmean had smaller but similar predictive power.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873767      PMCID: PMC4873546          DOI: 10.3109/0284186X.2012.702923

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  26 in total

Review 1.  Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  S T Martin; H M Heneghan; D C Winter
Journal:  Br J Surg       Date:  2012-02-23       Impact factor: 6.939

2.  18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

Authors:  Giuseppe Lucio Cascini; Antonio Avallone; Paolo Delrio; Cesare Guida; Fabiana Tatangelo; Pietro Marone; Luigi Aloj; Francesco De Martinis; Pasquale Comella; Valerio Parisi; Secondo Lastoria
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

3.  Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.

Authors:  Florent Tixier; Catherine Cheze Le Rest; Mathieu Hatt; Nidal Albarghach; Olivier Pradier; Jean-Philippe Metges; Laurent Corcos; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

4.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

5.  Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.

Authors:  Boon-Keng Teo; Youngho Seo; Stephen L Bacharach; Jorge A Carrasquillo; Steven K Libutti; Himanshu Shukla; Bruce H Hasegawa; Randall A Hawkins; Benjamin L Franc
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

6.  Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging.

Authors:  N Boussion; C Cheze Le Rest; M Hatt; D Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-18       Impact factor: 9.236

7.  Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma.

Authors:  Thomas Cazaentre; Franck Morschhauser; Maximilien Vermandel; Nacim Betrouni; Thierry Prangère; Marc Steinling; Damien Huglo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-30       Impact factor: 9.236

8.  Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

Authors:  Roy F A Vliegen; Regina G Beets-Tan; Bart Vanhauten; Ann Driessen; Michel Oellers; Alfons G Kessels; Ann Arens; Geerard L Beets; Jeroen Buijsen; Angela van Baardwijk; Dirk de Ruysscher; Guido Lammering
Journal:  Strahlenther Onkol       Date:  2008-09-19       Impact factor: 3.621

9.  Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Authors:  Carlo Capirci; Lucia Rampin; Paola A Erba; Fabrizio Galeotti; Giorgio Crepaldi; Elena Banti; Marcello Gava; Stefano Fanti; Giuliano Mariani; Pier Carlo Muzzio; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-15       Impact factor: 9.236

10.  Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy.

Authors:  Genevieve B Melton; William C Lavely; Heather A Jacene; Richard D Schulick; Michael A Choti; Richard L Wahl; Susan L Gearhart
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

View more
  13 in total

Review 1.  Computerized PET/CT image analysis in the evaluation of tumour response to therapy.

Authors:  W Lu; J Wang; H H Zhang
Journal:  Br J Radiol       Date:  2015-02-27       Impact factor: 3.039

2.  Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study.

Authors:  Shadi A Esfahani; Pedram Heidari; Elkan F Halpern; Ephraim P Hochberg; Edwin L Palmer; Umar Mahmood
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

3.  The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.

Authors:  Lucia Leccisotti; Maria Antonietta Gambacorta; Chiara de Waure; Antonella Stefanelli; Brunella Barbaro; Fabio Maria Vecchio; Claudio Coco; Roberto Persiani; Antonio Crucitti; Antonino Pio Tortorelli; Alessandro Giordano; Vincenzo Valentini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-17       Impact factor: 9.236

4.  FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.

Authors:  Pierre Lovinfosse; Marc Polus; Daniel Van Daele; Philippe Martinive; Frédéric Daenen; Mathieu Hatt; Dimitris Visvikis; Benjamin Koopmansch; Frédéric Lambert; Carla Coimbra; Laurence Seidel; Adelin Albert; Philippe Delvenne; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-18       Impact factor: 9.236

5.  Comparison of Quantitative Methods on FDG PET/CT for Treatment Response Evaluation of Metastatic Colorectal Cancer.

Authors:  Ji-In Bang; Yoojoo Lim; Jin Chul Paeng; Sae-Won Han; Sohyun Park; Jung Min Lee; Hyun Joo Kim; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; Tae-You Kim; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2016-09-13

6.  Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.

Authors:  Anne I J Arens; Esther G C Troost; Bianca A W Hoeben; Willem Grootjans; John A Lee; Vincent Grégoire; Mathieu Hatt; Dimitris Visvikis; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders; Eric P Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-18       Impact factor: 9.236

7.  Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.

Authors:  Shan Tan; Hao Zhang; Yongxue Zhang; Wengen Chen; Warren D D'Souza; Wei Lu
Journal:  Med Phys       Date:  2013-10       Impact factor: 4.071

8.  Predictive value of clinical and 18F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma.

Authors:  Lisa Marr; Bernhard Haller; Thomas Pyka; Jan C Peeken; Moritz Jesinghaus; Klemens Scheidhauer; Helmut Friess; Stephanie E Combs; Stefan Münch
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.379

9.  Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.

Authors:  Yoko Satoh; Atsushi Nambu; Tomoaki Ichikawa; Hiroshi Onishi
Journal:  BMC Cancer       Date:  2014-07-21       Impact factor: 4.430

10.  FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges.

Authors:  Nadia Withofs; Claire Bernard; Catherine Van der Rest; Philippe Martinive; Mathieu Hatt; Sebastien Jodogne; Dimitris Visvikis; John A Lee; Philippe A Coucke; Roland Hustinx
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.